

research communications
The structure of the Gemella haemolysans M26 IgA1 protease trypsin-like domain
aDepartment of Biology, University of Waterloo, Waterloo, ON N2L 3G1, Canada, and bDepartment of Biochemistry and Molecular Genetics, School of Medicine, University of Colorado Denver, Aurora, CO 80045, USA
*Correspondence e-mail: tholyoak@uwaterloo.ca
Gemella haemolysans (GhTrp). These structural data demonstrate that the GhTrp domain possesses a trypsin-like fold but contains significant deviations in the surface-loop structure that is known to be coupled to protease selectivity. The lack of observable catalytic function coupled with the structural data suggest that this domain may exist in a pro-enzyme-like state that can potentially be activated when the domain is N-terminally proteolytically excised from the larger M26 IgAP structure.
A (IgA) are a group of bacterial-derived enzymes that selectivity hydrolyze human IgA in the hinge region that is unique to this Several IgA protease (IgAP) families have evolved this ability using both metalloprotease and serine protease chemical mechanisms. One family of metal-dependent IgAPs is the M26 family. This family can be grouped into two subfamilies based upon the presence or absence of a trypsin-like domain found N-terminal to the IgAP domain. The role of this domain in IgAP structure and function is poorly understood. Here, we present the first structural characterization of an M26 IgAP trypsin-like domain fromKeywords: IgA proteases; serine proteases; trypsin; chymotrypsin; M26 proteases.
1. Introduction
et al., 2009; Wang et al., 2020
; Redzic et al., 2022
; Tran et al., 2024
).
The M26 IgAP family can be split into two subfamilies with distinct domain architectures. The subfamily represented by the Gemella haemolysans IgAP (GhIgAP) contains an additional trypsin-like domain (GhTrp) found N-terminal to the IgAP domain (Supplementary Fig. S1a; residues 684–8961; Redzic et al., 2022). This trypsin-like domain is missing from the other subfamily represented by the Streptococcus pneumoniae IgAP (Redzic et al., 2022
). Prior studies that compared GhIgAP constructs with and without this domain concluded that GhTrp had no effect on IgA1 proteolysis (Redzic et al., 2022
). This left the role of GhTrp in the context of the larger M26 IgAP structure open to further investigation (Redzic et al., 2022
). To gain insight into the structure and potential functional role of this domain, we solved the of GhTrp and demonstrated that the domain does indeed possess a trypsin-like protease fold. This fold, however, contains many unique changes in the well characterized surface loops that are known to contribute to trypsin-like protease specificity. The suggests that GhTrp, as it exists in the full-length M26 GhIgAP, may be an inactive pro-enzyme. We propose a mechanism of pro-enzyme activation through the proteolytic removal of the N-terminal region of the full-length enzyme from the GhTrp domain.
2. Materials and methods
2.1. Protein expression and purification
The trypsin-like domain of G. haemolysans IgAP (WP_040464465.1; residues 684–896; GhTrp) was cloned into pET-21b with an N-terminal His-tag and thrombin cleavage site as described previously (Redzic et al., 2022). Escherichia coli BL21(DE3) cells were transformed with this vector and used for recombinant protein expression. An overnight culture was inoculated into ZYP-5052 autoinduction medium (Studier, 2005
) at a ratio of 50 ml overnight culture to 1 l final medium volume with a minimum headspace:medium ratio of 1:1. ZYP-5052 medium was supplemented with 50 µg ml−1 kanamycin and the cells were grown at 20°C at 150 rev min−1 for 40–48 h, harvested at 6000g and the cell pellets were stored at −80°C.
All purification steps were carried out at 4°C. Cell pellets were thawed in buffer A (25 mM HEPES pH 7.5, 0.5 M NaCl, 10 mM imidazole), passed twice through a French pressure cell (Thermo Fisher Scientific, Waltham, Massachusetts, USA) at 7.6 MPa for cell lysis and debris was removed via high-speed centrifugation at 17 000g. The clarified cell lysate was then incubated with Ni–NTA resin (Qiagen) pre-equilibrated in buffer A for 1 h. The resin was first washed with ten column volumes (CV) of buffer B [25 mM HEPES pH 7.5, 0.1%(v/v) IGEPAL CA-630, 10 mM imidazole] to remove nonspecific hydrophobically bound contaminants, followed by a wash with 15 CV buffer A. The protein was eluted with buffer C (25 mM HEPES pH 7.5, 0.5 M NaCl, 300 mM imidazole). The Ni–NTA flowthrough was concentrated to less than 1 ml and loaded onto a pre-packed HiLoad Superdex 75 pg 16/600 column pre-equilibrated in crystallization buffer (25 mM HEPES pH 7.5) and run at 0.5 ml min−1. The purity of the protein in the non-aggregate absorbance peak was qualitatively analysed using SDS–PAGE. Pure fractions were concentrated, frozen in pellets by direct immersion in liquid nitrogen and stored at −80°C. Protein concentration was measured using a 1% mass extinction coefficient of 10.95, theoretically determined from the primary sequence of the protein (Gasteiger et al., 2005).
2.2. Protein crystallization
2.0 µl 10 mg ml−1 GhTrp was mixed with 2.0 µl reservoir solution [0.2 M KNO3, 22%(w/v) PEG 3350] in a hanging-drop crystallization tray. Thin plate clusters appeared after several days and were manually manipulated to acquire single crystals suitable for diffraction. Crystals were cryoprotected in 0.2 M KNO3, 25%(w/v) PEG 3350 supplemented with 20%(v/v) PEG 400 before being plunged into liquid nitrogen for data collection.
2.3. Data collection and processing
Diffraction data were collected on the CMCF-BM beamline at the Canadian Light Source (CLS) using a Dectris PILATUS3 S 6M. Data were indexed, integrated and scaled with DIALS (Winter et al., 2018) and imported into the CCP4 suite (Agirre et al., 2023
) with AIMLESS (Evans & Murshudov, 2013
). The structure was solved with phenix.mr_rosetta through a combination of ab initio modelling and (DiMaio et al., 2011
; Terwilliger et al., 2012
). was performed using phenix.refine (Afonine et al., 2012
) in conjunction with manual model building in Coot (Emsley et al., 2010
). Translation–libration–screw parameters were automatically determined and used by phenix.refine. Model geometry was analysed and optimized based on suggestions by MolProbity (Williams et al., 2018
). Data-collection and model statistics are summarized in Table 1
.
|
3. Results and discussion
3.1. Activity analysis of GhTrp
Several attempts at identifying potential substrates using small chromogenic peptide-based substrates as well as proteomic identification of protease cleavage sites (PICS) analysis against a bacterial (E. coli) peptide library (Eckhard et al., 2016) failed to demonstrate any measurable for GhTrp (data not shown).
3.2. Structure solution
A crystallographic property present in the GhTrp prevented initial structure solution. Due to the presence of translational (tNCS) in the crystal, the structure was unable to be solved using simple molecular-replacement strategies. The tNCS was identified by phenix.xtriage (Zwart et al., 2005), which showed a strong off-origin Patterson peak at (u, v, w) = (0.00, 0.06, −0.50) with a height of 28% of the Patterson origin peak. This structure was solved at a time (early 2021) when structural modelling techniques had yet to reach the more accurate predictive capabilities of AlphaFold (Jumper et al., 2021
) and RosettaFold (Baek et al., 2021
). The best search model identified through sequence alone only had ∼30% sequence identity and a Cα r.m.s.d. of ∼2.5 Å (PDB entry 1dt2), which may have been sufficient for determining phases if not for the artefacts associated with tNCS interfering with molecular-replacement techniques (Read et al., 2013
). This was nevertheless a better search model than the ∼3.0 Å Cα r.m.s.d. homology model predicted by I-TASSER at that time (Supplementary Fig. S2; Roy et al., 2010
). The structure was ultimately solved using phenix.mr_rosetta as this was one of the first programs that incorporated ab initio model building as part of the phasing process (DiMaio et al., 2011
; Terwilliger et al., 2012
). As expected, the GhTrp depicts two molecules in the related to each other along the c axis by a tNCS vector of approximately half the c-axis length (Supplementary Fig. S3).
3.3. The general fold shows modifications to trypsin-like specificity loops
Despite having low sequence identity (<20%) to most known chymotrypsin-like and trypsin-like DALI analysis (Holm, 2022) demonstrates that the fold of GhTrp is consistent with other members of the S1 family of glutamyl endopeptidases, as categorized by the MEROPS database (Rawlings et al., 2018
). GhTrp exhibits reasonable overall structural homology with this family of glutamyl endopeptidases, with the best-aligning structures having DALI scores of >18.5 and overall Cα r.m.s.d. values of between 2 and 2.8 Å despite sequence identities of 21% or less (Table 2
).
|
The trypsin-like fold has been well characterized and the involvement of the many surface loops as determinants of subsite selectivity for peptide and protein substrates has been well documented (reviewed in Goettig et al., 2019). An analysis of these surface loops in the structure of GhTrp demonstrates that there are considerable differences in the structures of the specificity loops between the classic trypsin structure and GhTrp, with the exception of loop C. Comparisons between the structures of GhTrp, bovine trypsin and Bacillus intermedius glutamyl peptidase (BGP; Fig. 1
) demonstrate that loops A and B are considerably larger in bovine trypsin and loops D and E are shorter in GhTrp than either of the other two enzymes. GhTrp therefore lacks the calcium-binding residues that stabilize the more elongated loop structure in bovine trypsin and thus no ions are observed in the structure of GhTrp (Leiros et al., 2001
).
![]() | Figure 1 A comparison of the loop structures of (a) GhTrp (PDB entry 9ect), (b) bovine trypsin (PDB entry 1hj9) and (c) Bacillus intermedius glutamyl-endopeptidase (PDB entry 1p3c). The known specificity loops, loop A (37 loop; dark orange), loop B (60 loop; cyan), loop C (99 loop; yellow), loop D (148 loop; maroon), loop E (75 loop; green), loop 1 (189 loop; magenta), loop 2 (220 loop; light blue) and loop 3 (175 loop; orange), are illustrated in each structure with the remaining protein rendered in grey. In (c), the location of the N-terminus is indicated by the N-terminal leucine residue rendered as a blue stick model. Potential interactions between members of the catalytic triad are rendered as dashed lines and the location of the S1 pocket is annotated. All molecules are presented in an identical orientation. |
In GhTrp and BGP, loop 3 forms additional β-strands that extend the core β-sheet, which is quite different from the helical structure found in bovine trypsin. Loop 1, which contains the serine (Ser167) and the oxyanion-hole residues (amides of Ser167/Gly165), is similar in structure between GhTrp and BGP but is truncated when compared with bovine trypsin. This may be a consequence of their correspondingly truncated loops 2, which act as a supporting structure for the placement of loop 1. As both loops 1 and 2 are truncated in GhTrp relative to bovine trypsin, loop 2 is still able to function as a backing structure for loop 1 in the fold.
Most notably, the conformation of loop 2 of GhTrp places it in the middle of the putative S1 pocket, bifurcating the substrate-binding groove (Fig. 2). This malformed S1 pocket is consistent with the functional data that demonstrate a lack of proteolytic function for this enzyme construct. In contrast, the the prime-side subsites are well structured. Taken together, these data suggest that the GhTrp structure could represent a pro-enzyme-like form of the putative zymogen in which some activation event is required to properly stabilize loop 2 in an active conformation to generate a viable S1 pocket. One could argue that the bifurcation of the S1 pocket may be the result of characterizing GhTrp outside the context of GhIgAP. However, the AlphaFold3 model of full-length GhIgAP shows a similar conformation of loop 2 in which it still bifurcates the S1 pocket, consistent with the persistence of the pro-enzyme-like conformation in the full-length enzyme (Supplementary Fig. S1b).
![]() | Figure 2 A comparison of the electrostatic surfaces of (a) GhTrp (PDB entry 9ect) and (b) B. intermedius glutamyl-endopeptidase (PDB entry 1p3c). In (b) the position of the S1 binding pocket is indicated by the MPD molecule that was co-crystallized (grey sticks coloured by atom type). In the GhTrp structure (a), the S1 pocket site is occluded by the structure of loop 2. Both molecules are presented in the same orientation as in Fig. 1 ![]() |
The N-termini of many trypsin-like serine Staphylococcus aureus exfoliative toxin A stabilizes the S1 pocket and deletions in the N-terminal region abolish activity (Cavarelli et al., 1997). An alternative explanation for this substrate-binding-groove bifurcation comes from examining the structure of BGP, where zymogen activation liberating the N-terminal leucine residue stabilizes a correct loop 2 conformation and formation of the S1 pocket (Fig. 1
c; Meijers et al., 2004
). In the crystallized construct, the N-terminus of GhTrp is too short to interact with loop 1 to stabilize an open, active conformation. Even if the N-terminus is extended by ∼30 amino acids, GhTrp remained inactive and this extra N-terminal tail was shown to lack a defined structure (Redzic et al., 2022
). If the GhTrp structure truly depicts a pro-enzyme, the activation mechanism for BGP suggests that the N-terminus of GhTrp must be cleaved at a specific site to properly activate GhTrp. Further support for this activation mechanism comes from the electron-density maps corresponding to loop 2, in which the distal end of this loop (residues 868–872) is poorly ordered in the in its modelled conformation (Fig. 3
). However, based upon the data, we cannot rule out the possibility that this domain of GhIgAP evolved from the trypsin protease fold, lost its ability to function as a protease and acquired a different, but as of yet unknown, function.
![]() | Figure 3 Apparent disorder in loop 2 (863–877) of GhTrp. The backbone and side chains are represented as stick models and coloured by atom type with C atoms in green. 2Fo − Fc density at 1σ is rendered as a blue mesh |
4. Conclusions
The GhTrp was solved to gain insight into the potential functions of this domain despite difficulties in finding a substrate for the putative enzyme. These structural data showed that the lack of activity observed is unsurprising due to the aberrant position of loop 2 occluding the S1 pocket in the and AlphaFold model. Based upon this result, we hypothesize that the current structure of GhTrp represents the pro-enzyme structure of the enzyme that is present in the full-length M26 IgAP. We hypothesize that this putative pro-enzyme form must undergo a specific cleavage event to generate an N-terminal segment that interacts with loop 2 to stabilize a more open and active conformation of the S1 pocket.
ofSupporting information
Supplementary Figures. DOI: https://doi.org/10.1107/S2053230X25001219/no5210sup1.pdf
Footnotes
1To be consistent with the numbering found in the deposited full-length structure of GhIgAP (PDB entry 7uvk), in the manuscript we have used the sequence numbering corresponding to NCBI entry WP_040464465.1, which is offset from the sequence found in the PDB deposition corresponding to UniProt entry C5NYF3 by 23 residues.
Acknowledgements
Part of the research described in this paper was performed using beamline CMCF-BM at the Canadian Light Source, a national research facility of the University of Saskatchewan, which is supported by the Canada Foundation for Innovation (CFI), the Natural Sciences and Engineering Research Council (NSERC), the National Research Council (NRC), the Canadian Institutes of Health Research (CIHR), the Government of Saskatchewan and the University of Saskatchewan.
Conflict of interest
The authors declare no conflicts of interest.
Data availability
The model coordinates and structure factors for GhTrp have been deposited in the PDB (https://www.rcsb.org/pdb) under accession code 9ect. The PDB deposition is cross-referenced with residues 661–873 of UniProt entry C5NYF3. It should be noted that this entry contains a sequence that lacks 23 N-terminal residues relative to the GhIgAP sequence used in this and previous literature (GenBank WP_040464465.1; residues 684–896).
Funding information
This work was supported in part by funds provided through a Discovery Grant issued to TH by the Natural Sciences and Engineering Research Council of Canada (NSERC).
References
Afonine, P. V., Grosse-Kunstleve, R. W., Echols, N., Headd, J. J., Moriarty, N. W., Mustyakimov, M., Terwilliger, T. C., Urzhumtsev, A., Zwart, P. H. & Adams, P. D. (2012). Acta Cryst. D68, 352–367. Web of Science CrossRef CAS IUCr Journals Google Scholar
Agirre, J., Atanasova, M., Bagdonas, H., Ballard, C. B., Baslé, A., Beilsten-Edmands, J., Borges, R. J., Brown, D. G., Burgos-Mármol, J. J., Berrisford, J. M., Bond, P. S., Caballero, I., Catapano, L., Chojnowski, G., Cook, A. G., Cowtan, K. D., Croll, T. I., Debreczeni, J. É., Devenish, N. E., Dodson, E. J., Drevon, T. R., Emsley, P., Evans, G., Evans, P. R., Fando, M., Foadi, J., Fuentes-Montero, L., Garman, E. F., Gerstel, M., Gildea, R. J., Hatti, K., Hekkelman, M. L., Heuser, P., Hoh, S. W., Hough, M. A., Jenkins, H. T., Jiménez, E., Joosten, R. P., Keegan, R. M., Keep, N., Krissinel, E. B., Kolenko, P., Kovalevskiy, O., Lamzin, V. S., Lawson, D. M., Lebedev, A. A., Leslie, A. G. W., Lohkamp, B., Long, F., Malý, M., McCoy, A. J., McNicholas, S. J., Medina, A., Millán, C., Murray, J. W., Murshudov, G. N., Nicholls, R. A., Noble, M. E. M., Oeffner, R., Pannu, N. S., Parkhurst, J. M., Pearce, N., Pereira, J., Perrakis, A., Powell, H. R., Read, R. J., Rigden, D. J., Rochira, W., Sammito, M., Sánchez Rodríguez, F., Sheldrick, G. M., Shelley, K. L., Simkovic, F., Simpkin, A. J., Skubak, P., Sobolev, E., Steiner, R. A., Stevenson, K., Tews, I., Thomas, J. M. H., Thorn, A., Valls, J. T., Uski, V., Usón, I., Vagin, A., Velankar, S., Vollmar, M., Walden, H., Waterman, D., Wilson, K. S., Winn, M. D., Winter, G., Wojdyr, M. & Yamashita, K. (2023). Acta Cryst. D79, 449–461. Web of Science CrossRef IUCr Journals Google Scholar
Baek, M., DiMaio, F., Anishchenko, I., Dauparas, J., Ovchinnikov, S., Lee, G. R., Wang, J., Cong, Q., Kinch, L. N., Schaeffer, R., Millán, C., Park, H., Adams, C., Glassman, C. R., DeGiovanni, A., Pereira, J. H., Rodrigues, A. V., van Dijk, A. A., Ebrecht, A. C., Opperman, D. J., Sagmeister, T., Buhlheller, C., Pavkov-Keller, T., Rathinaswamy, M. K., Dalwadi, U., Yip, C. K., Burke, J. E., Garcia, K. C., Grishin, N. V., Adams, P. D., Read, R. J. & Baker, D. (2021). Science, 373, 871–876. Web of Science CrossRef CAS PubMed Google Scholar
Cavarelli, J., Prévost, G., Bourguet, W., Moulinier, L., Chevrier, B., Delagoutte, B., Bilwes, A., Mourey, L., Rifai, S., Piémont, Y. & Moras, D. (1997). Structure, 5, 813–824. CrossRef CAS PubMed Web of Science Google Scholar
DiMaio, F., Terwilliger, T. C., Read, R. J., Wlodawer, A., Oberdorfer, G., Wagner, U., Valkov, E., Alon, A., Fass, D., Axelrod, H. L., Das, D., Vorobiev, S. M., Iwaï, H., Pokkuluri, P. R. & Baker, D. (2011). Nature, 473, 540–543. Web of Science CrossRef CAS PubMed Google Scholar
Eckhard, U., Huesgen, P. F., Schilling, O., Bellac, C. L., Butler, G. S., Cox, J. H., Dufour, A., Goebeler, V., Kappelhoff, R., Keller, U., Klein, T., Lange, P. F., Marino, G., Morrison, C. J., Prudova, A., Rodriguez, D., Starr, A. E., Wang, Y. & Overall, C. M. (2016). Matrix Biol. 49, 37–60. Web of Science CrossRef CAS PubMed Google Scholar
Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. (2010). Acta Cryst. D66, 486–501. Web of Science CrossRef CAS IUCr Journals Google Scholar
Evans, P. R. & Murshudov, G. N. (2013). Acta Cryst. D69, 1204–1214. Web of Science CrossRef CAS IUCr Journals Google Scholar
Gasteiger, E., Hoogland, C., Gattiker, A., Duvaud, S., Wilkins, M. R., Appel, R. D. & Bairoch, A. (2005). The Proteomics Protocols Handbook, edited by J. M. Walker, pp. 571–607. Totowa: Humana Press. Google Scholar
Goettig, P., Brandstetter, H. & Magdolen, V. (2019). Biochimie, 166, 52–76. Web of Science CrossRef CAS PubMed Google Scholar
Holm, L. (2022). Nucleic Acids Res. 50, W210–W215. Web of Science CrossRef CAS PubMed Google Scholar
Johnson, T. A., Qiu, J., Plaut, A. G. & Holyoak, T. (2009). J. Mol. Biol. 389, 559–574. Web of Science CrossRef PubMed CAS Google Scholar
Jumper, J., Evans, R., Pritzel, A., Green, T., Figurnov, M., Ronneberger, O., Tunyasuvunakool, K., Bates, R., Žídek, A., Potapenko, A., Bridgland, A., Meyer, C., Kohl, S. A. A., Ballard, A. J., Cowie, A., Romera-Paredes, B., Nikolov, S., Jain, R., Adler, J., Back, T., Petersen, S., Reiman, D., Clancy, E., Zielinski, M., Steinegger, M., Pacholska, M., Berghammer, T., Bodenstein, S., Silver, D., Vinyals, O., Senior, A. W., Kavukcuoglu, K., Kohli, P. & Hassabis, D. (2021). Nature, 596, 583–589. Web of Science CrossRef CAS PubMed Google Scholar
Leiros, H.-K. S., McSweeney, S. M. & Smalås, A. O. (2001). Acta Cryst. D57, 488–497. Web of Science CrossRef CAS IUCr Journals Google Scholar
Meijers, R., Blagova, E. V., Levdikov, V. M., Rudenskaya, G. N., Chestukhina, G. G., Akimkina, T. V., Kostrov, S. V., Lamzin, V. S. & Kuranova, I. P. (2004). Biochemistry, 43, 2784–2791. Web of Science CrossRef PubMed CAS Google Scholar
Rawlings, N. D., Barrett, A. J., Thomas, P. D., Huang, X., Bateman, A. & Finn, R. D. (2018). Nucleic Acids Res. 46, D624–D632. Web of Science CrossRef CAS PubMed Google Scholar
Read, R. J., Adams, P. D. & McCoy, A. J. (2013). Acta Cryst. D69, 176–183. Web of Science CrossRef CAS IUCr Journals Google Scholar
Redzic, J. S., Rahkola, J., Tran, N., Holyoak, T., Lee, E., Martín-Galiano, A. J., Meyer, N., Zheng, H. & Eisenmesser, E. (2022). Commun. Biol. 5, 1190. Web of Science CrossRef PubMed Google Scholar
Roy, A., Kucukural, A. & Zhang, Y. (2010). Nat. Protoc. 5, 725–738. Web of Science CrossRef CAS PubMed Google Scholar
Studier, F. W. (2005). Protein Expr. Purif. 41, 207–234. Web of Science CrossRef PubMed CAS Google Scholar
Terwilliger, T. C., DiMaio, F., Read, R. J., Baker, D., Bunkóczi, G., Adams, P. D., Grosse-Kunstleve, R. W., Afonine, P. V. & Echols, N. (2012). J. Struct. Funct. Genomics, 13, 81–90. CrossRef CAS PubMed Google Scholar
Tran, N., Frenette, A. & Holyoak, T. (2024). bioRxiv, 2024.12.31.630911. Google Scholar
Wang, Z., Rahkola, J., Redzic, J. S., Chi, Y.-C., Tran, N., Holyoak, T., Zheng, H., Janoff, E. & Eisenmesser, E. (2020). Nat. Commun. 11, 6063. Web of Science CrossRef PubMed Google Scholar
Williams, C. J., Headd, J. J., Moriarty, N. W., Prisant, M. G., Videau, L. L., Deis, L. N., Verma, V., Keedy, D. A., Hintze, B. J., Chen, V. B., Jain, S., Lewis, S. M., Arendall, W. B., Snoeyink, J., Adams, P. D., Lovell, S. C., Richardson, J. S. & Richardson, D. C. (2018). Protein Sci. 27, 293–315. Web of Science CrossRef CAS PubMed Google Scholar
Winter, G., Waterman, D. G., Parkhurst, J. M., Brewster, A. S., Gildea, R. J., Gerstel, M., Fuentes-Montero, L., Vollmar, M., Michels-Clark, T., Young, I. D., Sauter, N. K. & Evans, G. (2018). Acta Cryst. D74, 85–97. Web of Science CrossRef IUCr Journals Google Scholar
Zwart, P., Grosse-Kunstleve, R. W. & Adams, P. (2005). CCP4 Newsl. 43, 7. Google Scholar
This is an open-access article distributed under the terms of the Creative Commons Attribution (CC-BY) Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.